Oncology · Phase II

Top sponsors

• First People's Hospital 261 programs
• Chinese Academy of 198 programs
• George Institute for 118 programs
• United Therapeutics Europe 112 programs
• Telethon Foundation 91 programs
• Takeda 79 programs
• Regeneron UK 71 programs
• MSD Merck Sharp 63 programs
• Ningbo Cancer Hospital 62 programs
• Anaxis Pharma 57 programs
• AstraZeneca 52 programs
• HOFFMANN-LA ROCHE 50 programs

1. Tipifarnib

   Kura Oncology

   Leukemia, Myelomonocytic, Chronic

   phase 2 · small molecule · completed

   1 trial →

2. Tipifarnib

   Kura Oncology

   Thyroid Cancer

   phase 2 · small molecule · completed

   1 trial →

3. Tipifarnib

   Kura Oncology

   Relapsed or Refractory Peripheral T-Cell Lymphoma

   phase 2 · small molecule · completed

   1 trial →

4. Tiragolumab

   Hoffmann-La Roche

   Cervical Cancer

   phase 2 · small molecule · completed

   1 trial →

5. Tiragolumab for HNSCC, metastatic deficient mis…

   Disc Medicine

   HNSCC, metastatic deficient mismatch repair (dMMR)/MSI-high (MSI-H) tumors, irresectable or metastatic melanoma, locally advanced or metastatic solid tumor

   phase 2 · small molecule · active

   1 trial →

6. Tislelizumab

   BEONE MEDICINES AUS PTY LTD

   Gastroesophageal Adenocarcinoma

   phase 2 · small molecule · active

   1 trial →

7. Tislelizumab

   The First People's Hospital of Lianyungang

   HER2-positive or Mutated Advanced Colorectal Cancer

   phase 2 · small molecule · active

   1 trial →

8. Tislelizumab

   The First People's Hospital of Lianyungang

   Biliary Tract Tumor

   phase 2 · small molecule · active

   1 trial →

9. Tislelizumab

   The First People's Hospital of Lianyungang

   Pancreatic Neoplasms

   phase 2 · small molecule · active

   1 trial →

10. Tislelizumab

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Thyroid Cancer

    phase 2 · small molecule · active

    1 trial →

11. Tislelizumab

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    RECTAL NEOPLASMS

    phase 2 · small molecule · active

    1 trial →

12. Tislelizumab

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Head and Neck Squamous Cell Carcinoma

    phase 2 · small molecule · active

    1 trial →

13. Tislelizumab

    The First People's Hospital of Lianyungang

    Bladder Urothelial Carcinoma

    phase 2 · small molecule · completed

    1 trial →

14. Tislelizumab

    BEONE MEDICINES AUS PTY LTD

    Resectable Esophageal Squamous Cell Carcinoma

    phase 2 · small molecule · completed

    1 trial →

15. Tislelizumab

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Hepatocellular Carcinoma

    phase 2 · small molecule · active

    1 trial →

16. Tislelizumab

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Head and Neck Cancer

    phase 2 · small molecule · terminated

    1 trial →

17. Tislelizumab

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Esophageal Squamous Cell Carcinoma (ESCC)

    phase 2 · small molecule · active

    1 trial →

18. Tislelizumab

    Hospital Authority, Hong Kong

    Pancreatic Neoplasms

    phase 2 · small molecule · active

    1 trial →

19. Tislelizumab

    BEONE MEDICINES AUS PTY LTD

    Colorectal Cancer

    phase 2 · small molecule · completed

    1 trial →

20. Tislelizumab

    BeiGene

    Cervical Cancer

    phase 2 · mab · completed

    1 trial →

21. Tislelizumab

    BEONE MEDICINES AUS PTY LTD

    Advanced Unresectable Gastric Adenocarcinoma

    phase 2 · small molecule · active

    1 trial →

22. Tislelizumab (BGB-A317)

    BEONE MEDICINES AUS PTY LTD

    MSI-H/dMMR Solid Tumors

    phase 2 · small molecule · active

    1 trial →

23. Tislelizumab combined with chemotherapy

    The First People's Hospital of Lianyungang

    Rectal Cancer

    phase 2 · small molecule · active

    1 trial →

24. TmBU conditioning Regimen

    The First People's Hospital of Lianyungang

    Acute Myeloid Leukemia

    phase 2 · small molecule · active

    1 trial →

25. Tolecizumab (PCSK9 Inhibitor)

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Colon Adenocarcinoma

    phase 2 · small molecule · active

    1 trial →

26. Tolinapant, Tolinapant

    Taiho Pharma Netherlands B.V.

    Advanced Solid Tumors and Lymphomas that are metastatic or unresectable: Cohort#1:Recurrent/metastatic head and neck squamous cell carcinoma; #2:Relapsed/refractory diffuse large B-cell lymphoma; #3:Progressive, refractory or relapsed peripheral T-cell lymphoma; #4:Relapsed/refractory cutaneous T-cell lymphoma; #5: Other tumor types that may have sensitivity to ASTX660; # 6: Cervical carcinoma not responsive/relapsed after standard therapy

    phase 2 · small molecule · active

    1 trial →

27. Toripalimab

    Yongchang Zhang

    Advanced Non Small Cell Lung Cancer

    phase 2 · small molecule · completed

    1 trial →

28. Toripalimab

    Coherus Oncology

    Head and Neck Squamous Cell Carcinoma (HNSCC) - Recurrent/Metastatic (R/M)

    phase 2 · small molecule · active

    1 trial →

29. Toripalimab

    The First People's Hospital of Lianyungang

    Adenocarcinoma of the Stomach

    phase 2 · small molecule · active

    1 trial →

30. Toripalimab

    The First People's Hospital of Lianyungang

    Breast Cancer

    phase 2 · small molecule · active

    1 trial →

31. Toripalimab

    The First People's Hospital of Lianyungang

    Pancreatic Carcinoma

    phase 2 · small molecule · active

    1 trial →

32. Toripalimab

    The First People's Hospital of Lianyungang

    Upper Tract Urothelial Carcinoma

    phase 2 · small molecule · active

    1 trial →

33. Toripalimab

    The First People's Hospital of Lianyungang

    Small Cell Lung Cancer Limited Stage

    phase 2 · small molecule · terminated

    1 trial →

34. Toripalimab

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Triple-Negative Breast Cancer (TNBC)

    phase 2 · small molecule · active

    1 trial →

35. Toripalimab

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Tracheal Squamous Cell Carcinoma

    phase 2 · small molecule · active

    1 trial →

36. Toripalimab

    The First People's Hospital of Lianyungang

    Nasopharyngeal Carcinoma

    phase 2 · small molecule · active

    1 trial →

37. Toripalimab

    The First People's Hospital of Lianyungang

    Locally Advanced Colon Cancer

    phase 2 · small molecule · active

    1 trial →

38. Toripalimab

    Coherus Oncology

    Sinonasal Cancer

    phase 2 · small molecule · active

    1 trial →

39. Toripalimab

    The First People's Hospital of Lianyungang

    Urinary Bladder Neoplasms

    phase 2 · small molecule · active

    1 trial →

40. Toripalimab

    Coherus Oncology

    Localized Colon Carcinoma

    phase 2 · small molecule · active

    1 trial →

41. Toripalimab + Chemotherapy

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Thymic Epithelial Tumor

    phase 2 · small molecule · active

    1 trial →

42. Toripalimab + Chemotherapy

    Coherus Oncology

    Head and Neck Cancer

    phase 2 · small molecule · active

    1 trial →

43. Toripalimab+Nedaplatin+Albumin Paclitaxel

    The First People's Hospital of Lianyungang

    Locally Advanced Esophageal Squamous Cell Carcinoma

    phase 2 · small molecule · active

    1 trial →

44. Toripalimab-tpzi

    Coherus Oncology

    Squamous Cell Carcinoma

    phase 2 · small molecule · active

    1 trial →

45. Total Neoadjuvant Treatment

    The First People's Hospital of Lianyungang

    Biliary Tract Neoplasms

    phase 2 · small molecule · active

    1 trial →

46. Tovorafenib, Tovorafenib

    Lacuna Pharma Pty Ltd

    RAF-Altered, Recurrent or Progressive Low-Grade Glioma and Advanced Solid Tumors in pediatric patients

    phase 2 · small molecule · active

    1 trial →

47. Trametinib (GSK1120212)

    ADIAL PHARMACEUTICALS, INC.

    Melanoma

    phase 2 · small molecule · completed

    1 trial →

48. Transarterial chemoembolization

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Unresectable Colorectal Cancer

    phase 2 · other · active

    1 trial →

Frequently asked questions